ITEMS IN AFP WITH KEYWORD:
Postmenopausal women at high risk of developing breast cancer who take anastrozole for five years have a lower rate of developing invasive breast cancer during that time frame.
In some postmenopausal women at higher-than-average risk of breast cancer, tamoxifen and, to a lesser extent, raloxifene (Evista) will prevent the development of breast cancer. For every 1,000 women who receive the prophylaxis, there will be seven to nine fewer cases of diagnosed breast cancer. Canc...
Implementation of a universal mammographic screening program leads to an increase in the diagnosis of invasive breast cancer, because of improved detection of clinically significant cancer and overdiagnosis.
Screening mammography is one of an increasing number of clinical issues that will require rethinking the clinical mission and restructuring clinical practice to help patients make informed choices.
Breast cancer is the most common non–skin cancer and the second leading cause of cancer death in North American women. Mammography is the only screening test shown to reduce breast cancer–related mortality. There is general agreement that screening should be offered at least biennially to women 50 t...
Breast cancer–related death can be reduced through effective screening, which typically includes imaging, clinical examination, and self-examination or awareness. The American College of Obstetricians and Gynecologists recommends using all three techniques to screen for breast cancer.
Jan 15, 2012 Issue
Screening Mammography for Reducing Breast Cancer Mortality [FPIN's Clinical Inquiries]
Screening mammography reduces breast cancer mortality in women 40 to 49 years of age who have an average risk of breast cancer.
Although mammography can lead to false-positive results, emotional stress, and unnecessary biopsies, it appears to reduce deaths from breast cancer by about 15 percent.
Sep 15, 2010 Issue
Screening for Breast Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends biennial screening mammography for women 50 to 74 years of age.
The November 2009 U.S. Preventive Services Task Force (USPSTF) recommendation for breast cancer screening, while sparking much controversy, was not a radical departure from the previous 2002 recommendation. The USPSTF approached the recommendation update with the basic questions of what ages to star...